Abstract:OBJECTIVE:To investigate the clinical characteristics of thoracic sarcoidosis compared with multi-organ sarcoidosis. METHODS:The clinical data of 24 patients with thoracic sarcoidosis and 29 patients with multi-organ sarcoidosis histologically diagnosed at Beijing Tongren Hospital from 1995 to 2010 were retrospectively analyzed. The demographic data, clinical manifestations, diagnostic procedures, involved organs, serum angiotensin converting enzyme (ACE) levels, lung functions, and cellular characteristics of bronchoalveolar lavage fluid (BALF) were compared. RESULTS:No difference was found in the age of onset between the 2 groups [(49 ± 12), (48 ± 11) years old; t = 0.114, P > 0.05]. Multi-organ sarcoidosis was more frequent in females compared with thoracic sarcoidosis (13/24, 24/29; χ² = 5.094, P < 0.05), and 72.41% of the patients with multi-organ disease were females above 40 years old. The patients with thoracic sarcoidosis mostly presented first to respiratory physicians or chest surgeons, often with the symptoms of lung involvement. The manifestations of multi-organ sarcoidosis varied considerably and the patients might present to any clinical departments. Sarcoidosis with rare involvement of organs as the presenting symptoms was easy to be misdiagnosed. A higher incidence of systemic constitutional symptoms (25.0%, 58.6%; χ² = 6.043, P < 0.05) and a longer duration for definite diagnosis [1.75 (0.625 - 3.000), 6 (0 - 40) months; Z = -3.377, P < 0.01] were found in patients with multi-organ sarcoidosis compared with thoracic sarcoidosis. There was no difference in the serum ACE level between the 2 groups [(72 ± 33), (75 ± 59) U/L; t = -0.193, P > 0.05]. Although forced expiratory volume in one second (FEV(1))/forced vital capacity (FVC), FEV₁ %predicted (pred), FVC%pred and total lung capacity (TLC)%pred showed no difference (t = 0.134 - 0.683, P > 0.05), the diffusing capacity of the lung of carbon monoxide (D(LCO))%pred decreased more remarkably in multi-organ sarcoidosis [(84 ± 8), (69 ± 21); t = 2.674, P < 0.05]. The total cell count, alveolar lymphocyte percentage and CD₄/CD₈ ratio of BALF demonstrated no significant difference between the 2 groups (t = -0.628 - -0.367, P > 0.05), but the neutrophil percentage was significantly higher in multi-organ sarcoidosis compared with thoracic sarcoidosis [(10.9 ± 4.9)%, (5.1 ± 2.1)%; t = -4.187, P < 0.01]. CONCLUSIONS:Compared with thoracic sarcoidosis, multi-organ sarcoidosis seemed to be more common in females and more serious. Increased percentage of neutrophils in BALF may be a suggestive index for multiple organ involvements.

Airflow Obstruction in Sarcoidosis and the Influencing Factors

Analysis of the Bronchospopic Diagnosis of Sarcoidosis

Correlation between serum angiotensin converting enzyme activity and immune inflammation indexes, imaging features and lung function in stage Ⅱ sarcoidosis

Analysis of CT features of pulmonary sarcoidosis

[The Clinical Significance of Increased Neutrophils in Bronchoalveolar Lavage Fluid in Sarcoidosis].

[A Comparative Clinical Analysis of Thoracic Sarcoidosis and Multi-Organ Sarcoidosis].

Lung mechanics and their relationship to lung volumes in pulmonary sarcoidosis

Clinical Features Analysis of 84 Patients with Sarcoidosis

Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis.

Analysis of the clinical data and definition methods of 96 cases with sarcoidosis

Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis

Analysis of the parenchymal lung lesions in sarcoidosis and the pathological diagnostic procedures

The Association Between Air Pollution and Lung Function in Sarcoidosis and Implications for Health Disparities

Cystic lung in sarcoidosis: Clinico‐radiologic characteristic and evolution

Endobronchial lesions of sarcoidosis

A case of sarcoidosis associated with lung cancer

Pleural involvements in pulmonary sarcoidosis: A case report and review of the literature

Atypical Computed Tomography Manifestations of Pulmonary Sarcoidosis

[Clinical Analyses of Sarcoidosis with Ocular Involvement].

Progress of Inhaled Corticosteroids in Treatment of Pulmonary Sarcoidosis

[The value of bronchoscopy in the diagnosis of sarcoidosis]